ProfileGDS5678 / 1437825_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 54% 53% 53% 52% 52% 57% 57% 53% 53% 53% 53% 53% 54% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3998254
GSM967853U87-EV human glioblastoma xenograft - Control 23.2981453
GSM967854U87-EV human glioblastoma xenograft - Control 33.3126953
GSM967855U87-EV human glioblastoma xenograft - Control 43.2163252
GSM967856U87-EV human glioblastoma xenograft - Control 53.2167452
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5414257
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5564857
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2901853
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.270153
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.283553
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2957553
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2556353
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3517654
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.3015453